ALACHUA, Fla. (July 23, 2014) – RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is unveiling the new AlloWedge™ bicortical bone wedges and instrumentation set at the American Podiatric Medical Association (APMA) annual scientific meeting in Honolulu this week. AlloWedge grafts offer surgeons an alternative option for opening wedge osteotomies in the foot and ankle.
The AlloWedge bicortical grafts are pre-shaped and designed specifically for Cotton and Evans osteotomy procedures. The instrument set includes a full line of high quality instruments aimed at simplifying the procedure and decreasing overall preparation time.
The AlloWedge instrument set includes a wide footprint distractor, featuring a textured surface for a more controlled grip, and osteotomes with a sharp serrated edge, allowing for clean cuts. Also included are trials that match the size and shape of the graft to reduce errors in graft selection, tamps that include a textured surface to reduce slippage when inserting the grafts into place and a mallet that is balanced for control and accuracy.
“The AlloWedge grafts and their associated instrumentation showcase RTI’s expertise in both safe, biologic implants and high quality metal instrumentation,” said Brian K. Hutchison, president and chief executive officer of RTI Surgical. “Each instrument in the set was carefully designed based on surgeon feedback, guiding us in creating a more effective way to approach deformity corrections in the foot and ankle.”
The AlloWedge pre-shaped bicortical bone wedges and instrumentation set will be previewed at the RTI Surgical exhibit at booth 900 during the APMA meeting with an anticipated market launch later this summer. To learn more about RTI Surgical and AlloWedge, please visit RTI’s booth at APMA or contact your local RTI Surgical representative.
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). In addition, these statements are subject to risks associated with the Pioneer’s financial condition, business and operations and the integration of Pioneer’s business with ours. Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website atwww.sec.gov.
- Jenny Highlander, APR, CPRC
- Director, Corporate Communications
- jhighlander@rtix.com
- (386) 418-8888
